Clinical Trial Update: A Study to Evaluate the Safety and Immunogenicity of Oral Polio Vaccine Type 2 in Infants and Children [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating safety and immunogenicity of oral polio vaccine type 2 in infants and children completed, with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Poliomyelitis

Drugs mentioned

• Oral polio vaccine type 2 (oral polio vaccine type 2)

Snippet

Sponsor: Fidec Corporation | Conditions: Adverse Event Following Immunisation | Phase 4 | Status: COMPLETED | Results posted: 2020-08-14